PATENT CLAIM ANALYSIS

Application Number: 15906424
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["544", "280000"]

Abstract:
The invention provides compounds of Formula (I), immunogenic compositions and pharmaceutical compositions comprising such compounds and methods of using such compounds to treat diseases or disorders associated with Toll-Like Receptor 7 activity.

Claim (Index 11):
The method of  claim 1 , wherein,\n R 1  is \u2014NHR 6  or \u2014NHCHR 6 R 9 ; R 3  is H and R 4  is -L 4 R 12 ; or R 3  is -L 4 R 12  and R 4  is H; L 1  is \u2014(CH 2 ) m \u2014; L 4  is \u2014(CH 2 ) m \u2014; R 6  is \u2014C 4 -C 6 alkyl; R 9  is L 1 OH; R 12  is an unsubstituted 5-6 membered heterocycloalkyl having 1 to 2 heteroatoms independently selected from N and O; and each m is independently selected from 1, 2, 3, and 4.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 88.0
- Lexical Diversity: 1.2
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15307510', '15307525', '10947420', '12310597', '15320887']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8294300119205252
- 35 USC 102 Novelty (BERT): 0.6024485762788166
- Combined Prediction Score: 0.8067318683563544
- Mean Citation Score: 437.961316
- Max Citation Score: 558.81177
- Similarity Product: 476.5536847243667

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test